Latest publications

Dupilumab shows long-term safety and efficacy in moderate-to-severe atopic dermatitis patients enrolled in a phase 3 open-label extension study. Deleuran M, Thaçi D, Beck LA, De Bruin-Weller M, Blauvelt A, Forman S et al. J. Am. Acad. Dermatol. 2019 Jul 30

High occurrence of antihistamine resistance in patients with recurrent idiopathic angioedema. Hofman ZLM, Van West N, Hack CE, Knulst AC, Maas C, Röckmann H et al. Clin Transl Allergy 2019; 9:35

Intra-nodal nevi in sentinel node negative patients with cutaneous melanoma does not influence survival. De Beer FSA, Van Diest PJ, Sigurdsson V, El Sharouni M et al. J Eur Acad Dermatol Venereol 2019 Jul 18

Effects of shared medical appointments compared to individual appointments in children with atopic dermatitis: A pragmatic randomized controlled trial. Zijlstra WT, Van Os-Medendorp H, Fieten KB, Sinnema G, Bruijnzeel-Koomen CAFM, Zuithoff NPA et al. Clin. Exp. Allergy 2019 Aug; 49(8):1095-1106

Sesame oleosins are minor allergens. Ehlers AM, Rossnagel M, Brix B, Blankestijn MA, Le TM, Suer W et al. Clin Transl Allergy 2019; 9:32

Time to get rid of the Investigator's Global Assessment as the primary outcome for clinical trials in atopic dermatitis? De Bruin-Weller M et al. Br. J. Dermatol. 2019 Jul; 181(1):12-13

Sex matters: men with melanoma have a worse prognosis than women. El Sharouni MA, Witkamp AJ, Sigurdsson V, Van Diest PJ, Louwman MWJ, Kukutsch NA et al. J Eur Acad Dermatol Venereol 2019 Jun 27

Comparison of Survival Between Patients With Single vs Multiple Primary Cutaneous Melanomas. El Sharouni MA, Witkamp AJ, Sigurdsson V, Van Diest PJ et al. JAMA Dermatol 2019 Jun 26

European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period. Vestergaard C, Wollenberg A, Barbarot S, Christen-Zaech S, Deleuran M, Spuls P et al. J Eur Acad Dermatol Venereol 2019 Jun 23

The Role of Mobile Health Technologies in Allergy Care: an EAACI Position Paper. Matricardi PM, Dramburg S, Alvarez-Perea A, Antolín-Amérigo D, Apfelbacher C, Atanaskovic-Markovic M et al. Allergy 2019 Jun 22

Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study. Oosterhaven JAF, Voorberg AN, Romeijn GLE, De Bruin-Weller MS, Schuttelaar MLA et al. J. Dermatol. 2019 Aug; 46(8):680-685

Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2. Cork MJ, Eckert L, Simpson EL, Armstrong A, Barbarot S, Puig L et al. J Dermatolog Treat 2019 Jun 09:1-9

Probability of sentinel lymph node positivity in melanoma. El Sharouni MA, Witkamp AJ, Sigurdsson V, Van Diest PJ et al. Eur. J. Cancer 2019 Jul; 116:10-12

Dupilumab after the 2017 approval for the treatment of atopic dermatitis: what's new and what's next? Van der Schaft J, Thijs JL, De Bruin-Weller MS, Balak DMW et al. Curr Opin Allergy Clin Immunol 2019 Aug; 19(4):341-349

Management der Dupilumab-assoziierten Konjunktivitis beim atopischen Ekzem. Aszodi N, Thurau S, Seegräber M, De Bruin-Weller M, Wollenberg A et al. J Dtsch Dermatol Ges 2019 05; 17(5):488-492